C9ORF30 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.19260054556969E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.03499997461398E-09 |
Normal-vs-Stage2 |
1.161890E-03 |
Normal-vs-Stage3 |
3.91960000001301E-06 |
Normal-vs-Stage4 |
2.06879999999909E-05 |
Stage1-vs-Stage2 |
2.786000E-01 |
Stage1-vs-Stage3 |
3.817800E-01 |
Stage1-vs-Stage4 |
1.596160E-01 |
Stage2-vs-Stage3 |
7.053600E-01 |
Stage2-vs-Stage4 |
5.988000E-02 |
Stage3-vs-Stage4 |
7.827700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.60320020884342E-10 |
Normal-vs-AfricanAmerican |
9.95109999999411E-05 |
Normal-vs-Asian |
9.218500E-02 |
Caucasian-vs-AfricanAmerican |
7.736800E-01 |
Caucasian-vs-Asian |
3.434600E-01 |
AfricanAmerican-vs-Asian |
3.831000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.82189999975435E-07 |
Normal-vs-Female |
6.97875091049127E-12 |
Male-vs-Female |
1.800350E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.503400E-03 |
Normal-vs-Age(41-60Yrs) |
1.49329999477033E-08 |
Normal-vs-Age(61-80Yrs) |
8.99200003345868E-09 |
Normal-vs-Age(81-100Yrs) |
2.756500E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.559400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.017600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.659800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.343400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.749800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.713000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.701630E-02 |
Normal-vs-Grade 2 |
6.14189998859871E-09 |
Normal-vs-Grade 3 |
5.11740000375127E-08 |
Normal-vs-Grade 4 |
4.27179999999971E-05 |
Grade 1-vs-Grade 2 |
2.965200E-01 |
Grade 1-vs-Grade 3 |
1.367650E-01 |
Grade 1-vs-Grade 4 |
8.792600E-01 |
Grade 2-vs-Grade 3 |
8.658800E-01 |
Grade 2-vs-Grade 4 |
1.274430E-01 |
Grade 3-vs-Grade 4 |
1.154830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.94190227734248E-11 |
Normal-vs-ccB subtype |
1.82704999999173E-05 |
ccA subtype-vs-ccB subtype |
2.455000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.48180001602327E-09 |
Normal-vs-N1 |
2.212100E-02 |
N0-vs-N1 |
4.108200E-01 |
|
|